pramipexole has been researched along with haloperidol in 17 studies
| Studies (pramipexole) | Trials (pramipexole) | Recent Studies (post-2010) (pramipexole) | Studies (haloperidol) | Trials (haloperidol) | Recent Studies (post-2010) (haloperidol) |
|---|---|---|---|---|---|
| 1,103 | 219 | 517 | 20,330 | 1,753 | 3,294 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 8 (47.06) | 18.2507 |
| 2000's | 2 (11.76) | 29.6817 |
| 2010's | 7 (41.18) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chio, CL; Ensinger, HA; Huff, RM; Lajiness, ME; Mierau, J; Schneider, FJ | 1 |
| Andricopulo, AD; Moda, TL; Montanari, CA | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Mierau, J; Schingnitz, G | 1 |
| Lin, MY; Walters, DE | 1 |
| Gerlach, J; Peacock, L | 1 |
| Barnas, C; Heiden, A; Kasper, S; Laakmann, G; Pfolz, H; Volz, HP; Zeit, H | 1 |
| Kołodziejczyk, K; Maj, J; Rogóz, Z; Skuza, G | 1 |
| Hoffmann, WE; Hyslop, DK; Piercey, MF | 1 |
| Lorenc-Koci, E; Wolfarth, S | 1 |
| Fujiwara, RA; Siuciak, JA | 1 |
| Buck, K; Buerger, E; Ferger, B; Koros, E; Shimasaki, M; Voehringer, P | 1 |
| Deng, CM; Gao, YY; Li, Y; Mu, YL; Ou, BC; So, JH; Tan, ZB; Tang, M; Wang, YQ; Zhang, LQ; Zhu, ZR | 1 |
| Ananthan, S; Głowacka, U; Kosmowska, B; Ossowska, K; Wardas, J | 1 |
| Dehpour, AR; Imran Khan, M; Norouzi-Javidan, A; Ostadhadi, S | 1 |
| Delev, DP; Doncheva, ND; Kostadinov, ID; Mihaylova, AS; Zlatanova, HI | 1 |
1 review(s) available for pramipexole and haloperidol
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 trial(s) available for pramipexole and haloperidol
| Article | Year |
|---|---|
Pramipexole as adjunct to haloperidol in schizophrenia. Safety and efficacy.
Topics: Adult; Akathisia, Drug-Induced; Antipsychotic Agents; Benzothiazoles; Dopamine Agonists; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Female; Haloperidol; Humans; Male; Middle Aged; Pramipexole; Prospective Studies; Psychiatric Status Rating Scales; Schizophrenia; Schizophrenic Psychology; Thiazoles | 1997 |
15 other study(ies) available for pramipexole and haloperidol
| Article | Year |
|---|---|
Pramipexole binding and activation of cloned and expressed dopamine D2, D3 and D4 receptors.
Topics: Animals; Benzothiazoles; Binding, Competitive; Cells, Cultured; CHO Cells; Cricetinae; Dopamine Agonists; Humans; Pramipexole; Receptors, Dopamine; Receptors, Dopamine D2; Receptors, Dopamine D3; Receptors, Dopamine D4; Spiperone; Thiazoles | 1995 |
Hologram QSAR model for the prediction of human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2007 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Biochemical and pharmacological studies on pramipexole, a potent and selective dopamine D2 receptor agonist.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Benzothiazoles; Corpus Striatum; Dihydroxyphenylalanine; Dopamine; Dopamine Agents; Dyskinesia, Drug-Induced; Exploratory Behavior; Female; Haloperidol; Male; Medial Forebrain Bundle; Mice; Motor Activity; Norepinephrine; Parkinson Disease, Secondary; Pramipexole; Rats; Receptors, Dopamine D2; Rotation; Stereoisomerism; Synapses; Thiazoles | 1992 |
The D2 autoreceptor agonists SND 919 and PD 128483 decrease stereotypy in developing rats.
Topics: Aging; Aminoquinolines; Animals; Benzothiazoles; Dopamine Agents; Dose-Response Relationship, Drug; Female; Haloperidol; Male; Motor Activity; Pramipexole; Rats; Rats, Sprague-Dawley; Stereotyped Behavior; Thiazoles | 1994 |
Effects of several partial dopamine D2 receptor agonists in Cebus apella monkeys previously treated with haloperidol.
Topics: Administration, Oral; Amphetamine; Animals; Antipsychotic Agents; Behavior, Animal; Benzothiazoles; Cebus; Disease Models, Animal; Dopamine Agents; Dopamine D2 Receptor Antagonists; Dyskinesia, Drug-Induced; Dystonia; Ergolines; Female; Haloperidol; Lisuride; Male; Piperidines; Pramipexole; Quinpirole; Raclopride; Salicylamides; Thiazoles | 1993 |
The behavioural effects of pramipexole, a novel dopamine receptor agonist.
Topics: Animals; Antiparkinson Agents; Benzazepines; Benzothiazoles; Body Temperature; Catalepsy; Clozapine; Dopamine Agents; Dopamine Agonists; Dopamine Antagonists; Dose-Response Relationship, Drug; Drug Interactions; Dyskinesia, Drug-Induced; Haloperidol; Injections, Subcutaneous; Levodopa; Male; Mice; Motor Activity; Pramipexole; Rats; Rats, Wistar; Receptors, Dopamine D2; Receptors, Dopamine D3; Spiperone; Stereotyped Behavior; Sulpiride; Thiazoles | 1997 |
Excitation of type II anterior caudate neurons by stimulation of dopamine D3 receptors.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Aminoquinolines; Animals; Benzothiazoles; Caudate Nucleus; Dopamine Agonists; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Dose-Response Relationship, Drug; Electrophysiology; Haloperidol; Imidazoles; Neurons; Pramipexole; Quinpirole; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D2; Receptors, Dopamine D3; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Serotonin Receptor Agonists; Tetrahydronaphthalenes; Thiazoles | 1997 |
Efficacy of pramipexole, a new dopamine receptor agonist, to relieve the parkinsonian-like muscle rigidity in rats.
Topics: alpha-Methyltyrosine; Animals; Benzothiazoles; Dopamine Agonists; Dose-Response Relationship, Drug; Electromyography; Haloperidol; Male; Muscle Rigidity; Muscle, Skeletal; Parkinson Disease, Secondary; Pramipexole; Rats; Rats, Wistar; Reserpine; Thiazoles; Treatment Outcome | 1999 |
The activity of pramipexole in the mouse forced swim test is mediated by D2 rather than D3 receptors.
Topics: Animals; Benzothiazoles; Dopamine Agonists; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Drug Interactions; Haloperidol; Male; Mice; Mice, Knockout; Motor Activity; Pramipexole; Receptors, Dopamine D2; Receptors, Dopamine D3; Species Specificity; Swimming; Thiazoles | 2004 |
Continuous dopaminergic stimulation by pramipexole is effective to treat early morning akinesia in animal models of Parkinson's disease: A pharmacokinetic-pharmacodynamic study using in vivo microdialysis in rats.
Topics: Animals; Benzothiazoles; Catalepsy; Delayed-Action Preparations; Disease Models, Animal; Dopamine; Dopamine Agonists; Dyskinesia, Drug-Induced; Extracellular Space; Haloperidol; Infusion Pumps, Implantable; Injections, Subcutaneous; Male; Parkinson Disease; Parkinsonian Disorders; Photoperiod; Pramipexole; Rats; Rats, Wistar; Reserpine; Time Factors | 2010 |
Dopamine D2/D3 but not dopamine D1 receptors are involved in the rapid antidepressant-like effects of ketamine in the forced swim test.
Topics: Animals; Antidepressive Agents; Benzazepines; Benzothiazoles; Dizocilpine Maleate; Fluoxetine; Haloperidol; Ketamine; Male; Mice; Motor Activity; Pramipexole; Receptors, Dopamine D1; Receptors, Dopamine D2; Receptors, Dopamine D3; Receptors, N-Methyl-D-Aspartate; Swimming | 2015 |
Pramipexole at a Low Dose Induces Beneficial Effect in the Harmaline-induced Model of Essential Tremor in Rats.
Topics: Amisulpride; Animals; Anti-Dyskinesia Agents; Benzothiazoles; Disease Models, Animal; Dopamine Agonists; Dopamine Antagonists; Dose-Response Relationship, Drug; Essential Tremor; Haloperidol; Harmaline; Imidazoles; Male; Movement; Nitriles; Pramipexole; Pyridines; Rats, Wistar; Receptors, Dopamine D2; Receptors, Dopamine D3; Sulpiride; Tetrahydroisoquinolines; Tetrahydronaphthalenes; Treatment Outcome | 2016 |
Antidepressant effect of pramipexole in mice forced swimming test: A cross talk between dopamine receptor and NMDA/nitric oxide/cGMP pathway.
Topics: Animals; Antidepressive Agents; Arginine; Benzothiazoles; Cyclic GMP; Dizocilpine Maleate; Haloperidol; Immobilization; Injections, Intraperitoneal; Male; Methylene Blue; Mice; Motor Activity; N-Methylaspartate; NG-Nitroarginine Methyl Ester; Nitric Oxide; Pramipexole; Receptors, Dopamine; Signal Transduction; Sildenafil Citrate; Swimming | 2016 |
Effects of Pramipexole on Learning and Memory Processes in Naïve and Haloperidol-challenged Rats in Active Avoidance Test.
Topics: Animals; Avoidance Learning; Behavior, Animal; Dopamine Agonists; Dopamine Antagonists; Haloperidol; Learning; Locomotion; Male; Memory; Pramipexole; Rats; Rats, Wistar | 2019 |